Congenital generalized lipodystrophy (CGL) is a rare autosomal recessive disorder characterized by a near-total absence of ...

A weekly diabetes medication may replace painful daily hormone injections for patients with congenital generalised lipodystrophy (CGL). Early findings suggest that tirzepatide – used for diabetes and ...

A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as GLP-1 receptor agonists, including the popular name brands Ozempic, Wegovy, ...

Eli Lilly's tirzepatide has been shown to significantly ... over the weekend and simultaneously published in the New England Journal of Medicine – also showed that treatment with the dual ...

Tirzepatide, the active ingredient in ... according to research published Jan. 29 in The New England Journal of Medicine. Congenital generalized lipodystrophy — a disorder that significantly ...

After 52 weeks, around 52% of patients on a 5 mg dose of tirzepatide had an absence ... The data has also been published in the New England Journal of Medicine. More than 50% of patients in ...